Group One Trading, L.P. Coherus Bio Sciences, Inc. Transaction History

Group One Trading, L.P.

$3.01 Billion
Q2 2024

A detailed history of Group One Trading, L.P. transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 151,909 shares of CHRS stock, worth $109,374. This represents 0.01% of its overall portfolio holdings.

Number of Shares

151,909

Previous 217,641 30.2%

Holding current value

$109,374

Previous $520,000 49.62%

% of portfolio

0.01%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.58 - $2.51 $103,856 - $164,987	-65,732 Reduced 30.2%	151,909 $262,000
Q1 2024 May 10, 2024	SELL	$2.02 - $3.14 $250,108 - $388,782	-123,816 Reduced 36.26%	217,641 $520,000
Q4 2023 Feb 14, 2024	BUY	$1.59 - $3.85 $542,916 - $1.31 Million	341,457 New	341,457 $1.14 Million
Q2 2023 Aug 09, 2023	BUY	$3.79 - $8.3 $264,197 - $578,584	69,709 Added 1021.23%	76,535 $326,000
Q1 2023 May 12, 2023	SELL	$5.89 - $10.52 $67,511 - $120,580	-11,462 Reduced 62.67%	6,826 $46,000
Q4 2022 Feb 09, 2023	SELL	$5.69 - $10.07 $31,864 - $56,392	-5,600 Reduced 23.44%	18,288 $144,000
Q3 2022 Nov 09, 2022	BUY	$7.17 - $13.87 $160,464 - $310,410	22,380 Added 1484.08%	23,888 $230,000
Q2 2022 Aug 11, 2022	SELL	$5.86 - $13.23 $2,056 - $4,643	-351 Reduced 18.88%	1,508 $11,000
Q1 2022 May 12, 2022	SELL	$10.92 - $16.41 $101,719 - $152,859	-9,315 Reduced 83.36%	1,859 $24,000
Q4 2021 Feb 11, 2022	BUY	$15.81 - $18.99 $148,092 - $177,879	9,367 Added 518.37%	11,174 $178,000
Q3 2021 Nov 12, 2021	SELL	$12.68 - $17.79 $6,124 - $8,592	-483 Reduced 21.09%	1,807 $29,000
Q2 2021 Aug 10, 2021	SELL	$12.95 - $15.41 $3,936 - $4,684	-304 Reduced 11.72%	2,290 $32,000
Q1 2021 May 12, 2021	SELL	$14.42 - $21.39 $27,715 - $41,111	-1,922 Reduced 42.56%	2,594 $38,000
Q4 2020 Feb 10, 2021	SELL	$16.56 - $18.94 $225,066 - $257,413	-13,591 Reduced 75.06%	4,516 $78,000
Q3 2020 Nov 12, 2020	BUY	$17.41 - $19.89 $140,812 - $160,870	8,088 Added 80.73%	18,107 $332,000
Q2 2020 Aug 13, 2020	SELL	$14.43 - $19.16 $78,802 - $104,632	-5,461 Reduced 35.28%	10,019 $179,000
Q1 2020 May 13, 2020	BUY	$11.67 - $22.53 $17,224 - $33,254	1,476 Added 10.54%	15,480 $251,000
Q4 2019 Feb 10, 2020	SELL	$16.33 - $21.37 $124,924 - $163,480	-7,650 Reduced 35.33%	14,004 $252,000
Q3 2019 Nov 12, 2019	BUY	$16.3 - $23.37 $668 - $958	41 Added 0.19%	21,654 $439,000
Q2 2019 Aug 09, 2019	BUY	$13.1 - $22.1 $283,130 - $477,647	21,613 New	21,613 $478,000
Q1 2019 May 13, 2019	SELL	$8.38 - $15.5 $1,173 - $2,170	-140 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$8.65 - $16.28 $1,211 - $2,279	140 New	140 $1,000
Q2 2018 Aug 14, 2018	SELL	$10.25 - $17.45 $122,231 - $208,091	-11,925 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$9.1 - $13.7 $38,820 - $58,444	-4,266 Reduced 26.35%	11,925 $132,000
Q4 2017 Feb 09, 2018	SELL	$8.35 - $14.4 $185,562 - $320,011	-22,223 Reduced 57.85%	16,191 $142,000
Q3 2017 Nov 15, 2017	BUY	$11.1 - $14.5 $349,905 - $457,083	31,523 Added 457.45%	38,414 $513,000
Q2 2017 Aug 14, 2017	BUY	N/A	6,891	6,891 $99,000

Others Institutions Holding CHRS

# of Institutions

140

Shares Held

76.8M

Call Options Held

79.1K

Put Options Held

100K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $56M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Coherus Bio Sciences, Inc. Transaction History